BioCorRx Inc. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2023)
- Form of Murthy Director Agreement (Filed With SEC on January 23, 2023)
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2022)
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2021)
- Form of Galligan Director Agreement (Filed With SEC on February 22, 2021)
- Lock-Up Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)
- Conversion Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)
- Statement of Work 2 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)
- Statement of Work 1 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)
- Form of Director Agreement (Filed With SEC on March 7, 2019)
- Form of Director Agreement (Filed With SEC on February 22, 2019)
- Distributor Agreement with CereCare, LLC, dated December 8, 2017 (Filed With SEC on December 14, 2017)
- FORM OF (Filed With SEC on July 11, 2014)
- RESTATEMENT OF SUBLICENSE AGREEMENT (Filed With SEC on July 11, 2014)
- AMENDMENT TO AGREEMENT (Filed With SEC on June 25, 2014)
- 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705Tel ###-###-#### (Filed With SEC on September 20, 2013)
- Advertising Agreement, dated February 1, 2011, by and between FSP and Clear Channel Broadcasting (Filed With SEC on November 4, 2011)
